Search Result "BIBW 2992"
Irreversible EGFR Inhibitors in the Treatment of Advanced NSCLC
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 24 Year: 2014 Page: 3894-3900
Author(s): Paolo Maione,Antonio Rossi,Marianna Bareschino,Paola Claudia Sacco,Clorinda Schettino,Francesca Casaluce,Assunta Sgambato,Cesare Gridelli
Predictive Molecular Markers of Response to Epidermal Growth Factor Receptor(EGFR) Family-Targeted Therapies
Journal: Current Cancer Drug Targets
Volume: 10 Issue: 8 Year: 2010 Page: 799-812
Author(s): Sarah Barton, Naureen Starling, Charles Swanton
Next Generation Tyrosine Kinase Inhibitor (TKI): Afatinib
Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 9 Issue: 3 Year: 2014 Page: 382-393
Author(s): Suresh Kumar,Ritesh Agrawal
NRG1-ErbB Lost in Translation: A New Paradigm for Lung Cancer?
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 38 Year: 2017 Page: 4213-4228
Author(s): Domenico Trombetta,Antonio Rossi,Federico P. Fabrizio,A. Sparaneo,Paolo Graziano,Vito M. Fazio,Lucia A. Muscarella
Role of Erlotinib in Influencing the Quality of Life of Cancer Patients
Journal: Clinical Cancer Drugs
Volume: 8 Issue: 1 Year: 2021 Page: 1-9
Author(s): Deepika Purohit,Parijat Pandey
Novel Agents in the Management of Lung Cancer
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4291-4325
Author(s): B. Kennedy, F. Gargoum, B. Bystricky, D. R. Curran, T. M. OConnor
Biomarkers in Non-Small Cell Lung Cancer: Perspectives of Individualized Targeted Therapy
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2018 Page: 2070-2077
Author(s): Mateus N. Aoki,Marla K. Amarante,Carlos E.C. de Oliveira,Maria A. E. Watanabe
Beyond Trastuzumab: Overcoming Resistance to Targeted HER-2 Therapy in Breast Cancer
Journal: Current Cancer Drug Targets
Volume: 9 Issue: 2 Year: 2009 Page: 148-162
Author(s): Philippe L. Bedard, Evandro de Azambuja, Fatima Cardoso
Targeted Therapies and other Agents as First-Line Maintenance and Beyond: Particular Benefit in Pulmonary Adenocarcinoma Patients
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 1 Year: 2011 Page: 1640-1650
Author(s): F. Petrelli, K. Borgonovo, M. Cabiddu, M. Ghilardi, S. Barni
Irreversible Protein Kinase Inhibitors
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 2981-2994
Author(s): L. Garuti, M. Roberti, G. Bottegoni